Search

Ascensia MICROLET NEXT Adjustable Lancing Device, 5 Depth Settings

KWD 3.500

Brand
Ascensia
Category
Diabetes Care
1 +

Special Features

  • Smooth & portable testing: for use with microlet silicone-coated lancets for smooth entry
  • Adjustable depth settings: features 5 clearly visible depth settings to help minimize pain so you can test with confidence (1,2)
  • Built-in safety: locking endcap helps prevent accidental lancing and trigger button pushes lancet into skin
  • Minimal noise: smooth gliding mechanism minimizes noise and helps reduce the pain perception
  • Easy-to-use strip ejector: strip ejector pushes lancet out with no need to manually remove

Description

The easy-to-use MICROLET NEXT Lancing Device is designed to help minimize pain (1,2) so you can test with confidence at home or on-the-go. The MICROLET NEXT Lancing Device features 5 clearly visible depth settings and a locking endcap to prevent accidental lancing. MICROLET NEXT Lancing Device uses MICROLET silicone-coated lancets that glide smoothly into the skin. MICROLET NEXT Lancing Device also features a smooth gliding mechanism to minimize noise and help reduce pain perception. After use, the ejector button pushes the lancet out with no need to use your hand. Easy to use, MICROLET NEXT Lancing Device is as simple as preparing, lancing, and ejecting.
Established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes. Already including the world‐renowned CONTOUR range of blood glucose monitoring systems, we are committed to adding more innovative and life­changing products to our portfolio. Ascensia, the Ascensia Diabetes Care logo, Contour, Second-Chance, the Second-Chance logo, No Coding, the No Coding logo are trademarks and or registered trademarks of Ascensia Diabetes Care. References: 1. Ascensia Diabetes Care. Data on File. Styx Comparative Study Final Report. (September 2015). A total of 29 interviews were conducted in Saint Louis from August 3-7. Metaphase. 2. Heinemann, L. et al. (2008). Finger Pricking and Pain: A Never Ending Story. Journal of Diabetes Science and Technology, 2(5), 919-921.

Related Items


{"error":"Error","cart_limit":"You have too many items in your cart.","prod_limit":"You cannot add any more of this item"}